257 related articles for article (PubMed ID: 28778960)
21. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
Furuta M; Sakakibara-Konishi J; Kikuchi H; Yokouchi H; Nishihara H; Minemura H; Harada M; Yamazaki S; Akie K; Fujita Y; Takamura K; Kojima T; Harada T; Minami Y; Watanabe N; Oizumi S; Suzuki H; Nishimura M; Dosaka-Akita H; Isobe H;
Oncologist; 2019 Nov; 24(11):e1172-e1179. PubMed ID: 31068386
[TBL] [Abstract][Full Text] [Related]
22. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
23. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
24. Emerging drugs for small-cell lung cancer.
Metro G; Cappuzzo F
Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
[TBL] [Abstract][Full Text] [Related]
25. The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.
Nosaki K; Seto T
Curr Treat Options Oncol; 2015 Dec; 16(12):56. PubMed ID: 26467930
[TBL] [Abstract][Full Text] [Related]
26. Current Diagnosis and Management of Small-Cell Lung Cancer.
Wang S; Zimmermann S; Parikh K; Mansfield AS; Adjei AA
Mayo Clin Proc; 2019 Aug; 94(8):1599-1622. PubMed ID: 31378235
[TBL] [Abstract][Full Text] [Related]
27. Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
Senan S; Okamoto I; Lee GW; Chen Y; Niho S; Mak G; Yao W; Shire N; Jiang H; Cho BC
Clin Lung Cancer; 2020 Mar; 21(2):e84-e88. PubMed ID: 31948903
[TBL] [Abstract][Full Text] [Related]
28. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
[TBL] [Abstract][Full Text] [Related]
29. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
30. Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pair.
Rath B; Plangger A; Krenbek D; Hochmair M; Stickler S; Tretter V; Hamilton G
Anticancer Drugs; 2022 Mar; 33(3):300-307. PubMed ID: 34924498
[TBL] [Abstract][Full Text] [Related]
31. Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.
Simone CB; Bogart JA; Cabrera AR; Daly ME; DeNunzio NJ; Detterbeck F; Faivre-Finn C; Gatschet N; Gore E; Jabbour SK; Kruser TJ; Schneider BJ; Slotman B; Turrisi A; Wu AJ; Zeng J; Rosenzweig KE
Pract Radiat Oncol; 2020; 10(3):158-173. PubMed ID: 32222430
[TBL] [Abstract][Full Text] [Related]
32. SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
García-Campelo R; Sullivan I; Arriola E; Insa A; Juan Vidal O; Cruz-Castellanos P; Morán T; Reguart N; Zugazagoitia J; Dómine M
Clin Transl Oncol; 2023 Sep; 25(9):2679-2691. PubMed ID: 37418123
[TBL] [Abstract][Full Text] [Related]
33. Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations.
Sun A; Abdulkarim B; Blais N; Greenland J; Louie AV; Melosky B; Schellenberg D; Snow S; Liu G
Lung Cancer; 2023 May; 179():107166. PubMed ID: 36944282
[TBL] [Abstract][Full Text] [Related]
34. Treatment advances in small cell lung cancer (SCLC).
Waqar SN; Morgensztern D
Pharmacol Ther; 2017 Dec; 180():16-23. PubMed ID: 28579387
[TBL] [Abstract][Full Text] [Related]
35. Thoracic Surgery in Early-Stage Small Cell Lung Cancer.
Low M; Ben-Or S
Thorac Surg Clin; 2018 Feb; 28(1):9-14. PubMed ID: 29150041
[TBL] [Abstract][Full Text] [Related]
36. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
Horn L; Reck M; Spigel DR
Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
[TBL] [Abstract][Full Text] [Related]
37. Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease.
Socinski MA; Kaye FJ; Spigel DR; Kudrik FJ; Ponce S; Ellis PM; Majem M; Lorigan P; Gandhi L; Gutierrez ME; Nepert D; Corral J; Ares LP
Clin Lung Cancer; 2017 Jan; 18(1):68-76.e2. PubMed ID: 28341109
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
Yao Y; Li B; Song R; Yang L; Zou B; Wang L
Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
[TBL] [Abstract][Full Text] [Related]
39. Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer.
An C; Jing W; Zhang Y; Liu S; Wang H; Zhu K; Kong L; Guo H; Zhu H
Future Oncol; 2017 Jun; 13(13):1149-1158. PubMed ID: 28326834
[TBL] [Abstract][Full Text] [Related]
40. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Bayman E; Etiz D; Akcay M; Ak G
Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]